FDA Makes 'Significant Changes' To Drug Registration Rules

05 Sep 2016
News

Joanne S. Eglovitch joanne.eglovitch@informa.com

Executive Summary

FDA on Sept. 1 issued a final rule that requires firms to electronically submit drug registration information and clarifies who must register their establishments. The final rule goes into effect on Nov. 30, more than 10 years first proposed.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Manufacturing Regulation BioPharmaceutical

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS119070

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS119070

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

FDA Makes 'Significant Changes' To Drug Registration Rules

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert